TrialBritish journal of cancer2020

TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial.

Daniel H Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.